Skip to main content
. 2019 Dec 18;15(5):499–510. doi: 10.1080/15592294.2019.1699695

Table 2.

Cognitive domain outcomes (N = 58).

Cognitive domain Baseline (prior to their receipt of chemotherapy) 6-month after the initiation of chemotherapy 1-year after the initiation of chemotherapy F (P-value)
Memory 97.4 (13.9)
[67, 127]
98.2 (19.6)
[41, 140]
98.5 (17.6)
[51, 126]
0.102 (.903)
Psychomotor speed 114.0 (23.5)
[62, 172]
117.4 (27.1)
[39, 186]
120.8 (26.4)
[39, 190]
7.180 (.001)
Reaction time 99.3 (17.1)
[39, 126]
103.0 (15.6)
[36, 130]
105.9 (12.9)
[54, 133]
18.193 (<.001)
Complex attention 99.8 (13.8)
[64, 121]
101.9 (19.1)
[38, 121]
106.0 (12.5)
[39, 121]
6.775 (.002)
Cognitive flexibility 98.4 (16.4)
[58, 127]
104.2 (20.3)
[27, 126]
108.2 (14.8)
[40, 131]
21.673 (< .001)

Values are standardized scores and presented as mean and standard deviation (SD). The minimum and maximum values (range) were presented under the mean scores. As higher scores on reaction time and complex attention domains indicate lower cognitive function, they were reversed scored for the analysis.

P < .05 denotes significant differences between three time points.